Quinebaug Day Treatment Program

Quinebaug Day Treatment Program

Services:
Language Services
• Sign language services for the deaf and hard of hearing

Detoxification (medical withdrawal) Services

• Medication routinely used during detoxification
• Opioids detoxification

Facility Vaping Policy

• Vaping permitted in designated area

Ancillary Services

• Social skills development
• Suicide prevention services
• Mental health services
• Transportation assistance

Type of Opioid Treatment

• Buprenorphine detoxification
• Accepts clients using MAT but prescribed elsewhere
• Prescribes naltrexone
• Prescribes buprenorphine
• Buprenorphine maintenance
• Relapse prevention with naltrexone

Pharmacotherapies

• Naltrexone (extended-release, injectable)
• Medication for mental disorders
• Naltrexone (oral)
• Buprenorphine with naloxone
• Buprenorphine without naloxone
• Acamprosate (Campral®)
• Clonidine
• Nicotine replacement

Type of Alcohol Use Disorder Treatment

• This facility administers/prescribes medication for alcohol use disorder
• Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere

Assessment/Pre-treatment

• Screening for mental disorders
• Screening for tobacco use
• Comprehensive substance use assessment
• Screening for substance use
• Comprehensive mental health assessment

Other Services

• Treatment for other addiction disorder

Payment/Insurance/Funding Accepted

• IHS/Tribal/Urban (ITU) funds
• Private health insurance
• Cash or self-payment
• Medicare
• Federal military insurance (e.g., TRICARE)
• Medicaid
• State-financed health insurance plan other than Medicaid

Transitional Services

• Aftercare/continuing care
• Discharge Planning
• Naloxone and overdose education

Hospitals

• Psychiatric hospital

Testing

• Drug or alcohol urine screening
• Drug and alcohol oral fluid testing
• Breathalyzer or blood alcohol testing

External Opioid Medications Source

• In-network prescribing entity

Type of Care

• Substance use treatment
• Detoxification
• Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children

Opioid Medications used in Treatment

• Buprenorphine used in Treatment
• Naltrexone used in Treatment

External Source of Medications Used for Alcohol Use Disorder Treatment

• Other contracted prescribing entity
• No formal relationship with prescribing entity
• In-network prescribing entity

Special Programs/Groups Offered

• Young adults
• Clients with co-occurring mental and substance use disorders

Facility Operation (e.g., Private, Public)

• Private non-profit organization

Facility Smoking Policy

• Smoking permitted in designated area

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Outpatient day treatment or partial hospitalization
• Outpatient methadone/buprenorphine or naltrexone treatment
• Outpatient detoxification
• Intensive outpatient treatment
• Outpatient

Treatment Approaches

• Anger management
• Trauma-related counseling
• Relapse prevention
• Telemedicine/telehealth therapy
• Cognitive behavioral therapy
• Motivational interviewing
• Brief intervention
• Substance use disorder counseling
• 12-step facilitation

Education and Counseling Services

• Substance use disorder education
• Smoking/vaping/tobacco cessation counseling
• Group counseling

Age Groups Accepted

• Children/Adolescents

Recovery Support Services

• Self-help groups
• Housing services
• Assistance with obtaining social services

License/Certification/Accreditation

• State department of health
• The Joint Commission
• Hospital licensing authority

Gender Accepted

• Male
• Female